1. N-Phenylmaleimide irreversibly inhibits pyruvate transport into rat heart and liver mitochondria to a much greater extent than does N-ethylmaleimide, iodoacetate or bromopyruvate. a-Cyanocinnamate protects the pyruvate transporter from attack by this thiol-blocking reagent. 2. In both heart and liver mitochondria a-cyanocinnamate diminishes labelling by [3HIN-phenylmaleimide of a membrane protein of subunit mol.wt. 15 000 on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. 3. Exposure of mitochondria to unlabelled N-phenylmaleimide in the presence of a-cyanocinnamate, followed by removal of a-cyanocinnamate and exposure to [3H]N-phenylmaleimide, produced specific labelling of the same protein. 4. Both labelling and kinetic experiments with inhibitors gave values for the approximate amount of carrier present in liver and heart mitochondria of 100 and 450 pmol/mg of mitochondrial protein respectively. 5. The turnover numbers for net pyruvate transport and pyruvate exchange at 0°C were 6 and 200 min-1 respectively.
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Pyruvate enters mitochondria by a transport mechanism that is specifically inhibited by a-cyanocinnamate derivatives (Halestrap & Denton, 1974; Halestrap, 1975 Halestrap, , 1976 Halestrap, , 1978a Halestrap et al., 1980) . It has been reported that pyruvate transport may also be inhibited by thiol-blocking reagents such as iodoacetate and N-ethylmaleimide (Papa & Paradies, 1974; Halestrap, 1976; Paradies & Papa, 1978) , and Halestrap (1976 and Halestrap ( , 1978a and Halestrap et al. (1980) have proposed that a-cyanocinnamate also inhibits by binding reversibly to an intramitochondrial thiol group.
Identification of several mitochondrial carriers has been achieved by specific labelling techniques (Klingenberg, 1976a; Klingenberg et al., 1978; Aquila et al., 1978; Heaton et al., 1978; Wohlrab, 1979; Hofmann & Kadenbach, 1979) . In the case of the adenine nucleotide translocase the protection that carboxyatractylate affords the carrier from attack by thiol-blocking reagents and 8-azido-ATP can be used to identify the carrier protein (Klingenberg, 1976b ; Heaton et al., 1978; Wohlrab, 1979) . A similar technique has been used to identify the mitochondrial phosphate transporter by using organomercurials to protect essential thiol groups (Coty & Pedersen, 1975; Hadvary & Kadenbach, 1976) .
Abbreviation used: SDS, sodium dodecyl sulphate.
In the present paper we investigate the use of a-cyanocinnamate to protect the pyruvate transporter from inactivation by thiol-blocking reagents. In addition, we demonstrate that the reversible protection afforded by a-cyanocinnamate allows identification of the carrier after labelling of heart and liver mitochondrial proteins with [3H]Nphenylmaleimide. Separation of the labelled mitochondrial proteins by SDS/polyacrylamide-gel electrophoresis showed the protein to have a molecular weight of about 15000 and to be present at about 100 and 450pmol/mg of protein in liver and heart mitochondria respectively. These values agree closely with those derived kinetically by titration of pyruvate transport activity with the inhibitor a-cyano-f,-(1-phenylindol-3-yl)acrylate.
Experimental

Chemicals
Unless stated below, all chemicals, biochemicals and radiochemicals were obtained from the sources given previously (Halestrap 1975 (Halestrap , 1978a . NPhenylmaleimide was synthesized from aniline and maleic anhydride by the method of Cava et al. (1961) . The 3H-labelled compound was prepared similarly but on a micro scale from (50,uCi/pmol) obtained from The Radiochemical Centre (Amersham, Bucks., U.K.).
Mitochondria
Rat liver mitochondria were prepared as described by Chappell & Hansford (1972) , and rat heart mitochondria by using a Polytron PT 10 tissue homogenizer as described by Halestrap (1975) . The isolation medium contained 250mM-sucrose, 10mM-Tris/HCl buffer and 2mM-EGTA at pH7.4. The mitochondria always demonstrated a control ratio of greater than 3 with succinate as substrate. Mitochondrial protein was measured by a modified biuret method (Gornall et al., 1949) .
Measurement ofmitochondrialparameters
Mitochondrial volumes and the accumulation of pyruvate and acetate by mitochondria were measured as described previously (Halestrap & Denton, 1974; Halestrap & McGivan, 1979) . Rat liver mitochondria (approx. 4mg of mitochondrial protein) were suspended in 1 ml of medium containing 250 mM-sucrose, 20mM-4-morpholinepropanesulphonic acid, 1 mM-KCl, 3 mM-ascorbate, 50,uM-NNN'N'-tetramethylphenylenediamine, 0.5 mM-EGTA, luM-valinomycin, l1uM-rotenone and either [6, uCi/ml) or [U-'4C]sucrose (0.1,uCi/ml), depending on the isotopic form of the compound being taken up. The medium was at pH7.0 and maintained at 60C. The mitochondria were preincubated for 3 min before the addition of either [2-14Clpyruvate (0.15 mm, 0. lpCi/ ml), [3Hlacetate (0.15mm, 0.5,Ci/ml) or 3H20 (l,uCi/ml). The mitochondria were separated from the medium after the required incubation period by rapid centrifugation at 9000g for 1 min in an Eppendorf 3200 centrifuge. The pellet and supernatant were separated and acidified with HCl04 (final concn. 2%, w/v), and the mitochondrial contents of pyruvate, acetate or water were determined by assay of 3H and 14C as described previously (Halestrap & Denton, 1974) . Oxidation of pyruvate by rat heart mitochondria was studied polarographically as described by Halestrap (1975 Separation of a crude inner-membrane fraction was achieved by centrifugation for 50000g-min. The protein concentration of this fraction was measured on a parallel membrane preparation from the same labelled mitochondria by the method of Lowry et al. (1951) , with bovine serum albumin as standard. The pellet, which contained all the mitochondrial succinate dehydrogenase activity but only 50% of the initial protein, was dissolved in sample buffer (20mM-sodium phosphate, 40mg of SDS/ml, 700mM-2-mercaptoethanol, 0.2mg of Bromophenol Blue/ml and 200mg of sucrose/ml, pH7.0), and proteins were separated by discontinuous SDS/ polyacrylamide-gel electrophoresis by using the method of Laemmli (1970) . Slab gels (14cm x 14cm) of 1cm track width and 12.5% (w/v) polyacrylamide were used, and each track was loaded to an identical protein concentration. After electrophoresis at 35mA/slab for 3-4h, when the dye front reached 1 cm from the bottom of the gel, the gel was fixed for 30min in 50% (v/v) methanol containing 1 M-trichloroacetic acid before staining of the proteins with Coomassie Brilliant Blue. After being destained, gels were prepared for fluorography by soaking in scintillator [20% (w/v) 2,5-diphenyloxazole in dimethyl sulphoxidel for 4 h as described by Bonner & Laskey (1974) before being dried down and exposed to pre-activated film (Kodak X-Omat) at -700C (Laskey & Mills, 1975) . Purified proteins were used for molecular-weight determinations, and for assessment of the 3H radioactivity (d.p.m.) represented by bands in the fluorograph [3HIN-phenylmaleimide-labelled lysozyme of known radioactivity was included. This was prepared by incubating lysozyme (5 mg/ml) with 50, Ci/, umol) in 20mM-Tris/HCl buffer, pH7.8, for 20minm at room temperature. The incubation medium was then diluted 5-fold with water, and the protein was precipitated with trichloroacetic acid (10%, w/v).
The precipitate was washed several times with trichloroacetic acid (10%, w/v) before being dissolved in sample buffer at about 1 mg/ml. The amount of 3H incorporated into the protein was determined by dialysing portions of the standards against fresh sample buffer and assaying the dialysis residue for 3H by liquid-scintilation counting. Fluorographs were scanned at 625 nm with a Gilford linear densitometer connected to a Hewlett Packard 9845S computer, which allowed highly flexible data manipulation, display and storage. Peak areas were calculated by this means and could be corrected to d.p.m. by comparison with the peak area of the 3H-labelled lysozyme standard.
Results
Inhibition of pyruvate transport by thiol-blocking reagents
The data in Table 1 investigate the effects of various thiol-blocking reagents on mitochondrial pyruvate transport in order to identify a suitable labelling reagent. As reported by others (Papa & Paradies, 1974; Halestrap, 1976) , various thiolblocking reagents inhibit pyruvate uptake into the mitochondria, but it can be seen that many of them also inhibit the accumulation of acetate. Since this (Halestrap, 1975) (Halestrap, 1978a) . A similar conclusion was reached by Pande & Parvin (1978 (Table  2) , which is a well-documented effect of some thiol-blocking reagents (Brierley et al., 1973 (Halestrap, 1975 (Halestrap, , 1976 ). Higher concentrations of N-phenylmaleimide than 1 mm appeared to cause mitochondrial damage sufficient to prevent accurate determination of the rate of pyruvate transport.
Protection ofmitochondria by a-cyanocinnamate
The data of Table 2 investigate whether acyanocinnamate can protect the pyruvate carrier from inhibition by N-phenylmaleimide. Mitochondria were incubated in sucrose medium in the presence or in the absence of a-cyanocinnamate (0.1 mM) and/or N-phenylmaleimide (1 mM). Uncoupler was present to enhance the interaction of a-cyanocinnamate with the mitochondria (Halestrap, 1975 (Halestrap, , 1978b (Halestrap, 1975; Halestrap & Denton, 1975 (Fig. 1) shows, extensive labelling of at least 50% of the stained proteins, and the intensity of some of the labelled proteins strongly suggets multi-site labelling. Careful computer analysis (see the Experimental section) of the scans of fluorographs exposed for various times showed that a-cyanocinnamate induced no changes in labelling of any of the major protein bands. In contrast, carboxyatractylate induced a major decrease in the peak height of a protein of mol.wt. 28000 (Fig. 1) , which confirms reports of others (Klingenberg, 1976b; Heaton et al., 1978; Wohlrab, 1979 ) that labelling of the ATP/ADP carrier by thiol-blocking reagents is diminished by carboxyatractylate. Longer exposure of fluorographs revealed a minor peak of radioactivity, running at the same position as 3H-labelled lysozyme, whose labelling was decreased by a-cyanocinnamate in both heart and liver mitochondria (Figs. 2a and 2b) . However, in liver mitochondria in particular this peak appeared as a shoulder of a larger peak (Fig.  2a ) and proved to be impossible to resolve completely.
Double-labelling experiments
Greater resolution of the protein whose labelling was protected by a-cyanocinnamate was achieved by a double treatment with N-phenylmaleimide. The mitochondria were first incubated with unlabelled N-phenylmaleimide in the presence or in the absence of a-cyanocinnamate in order to block most of the reactive thiol groups. After removal of a-cyanocinnamate the mitochondria were exposed to [3HIN-phenylmaleimide to label any thiol groups that were previously protected or unmodified for other reasons. Scans of fluorographs from the SDS/ polyacrylamide-gel electrophoresis resulting from these experiments are shown in Figs. 3(a) and 3(b). In both heart and liver mitochondria the labelling of proteins is much diminished in comparison with the single-label experiments (Fig. 1) , and again the presence of a-cyanocinnamate in the first incubation affects the subsequent labelling of a protein of mol.wt. 15000. In this case, however, the resolution is much clearer, and as predicted the first incubations, which were in the presence of acyanocinnamate, gave greater labelling of this protein with [3HIN-phenylmaleimide in the second incubation. In heart mitochondria, in two out of five experiments, a second protein, of mol.wt. 12000, also showed slightly enhanced labelling as a result of prior protection by a-cyanocinnamate. The absence of such a peak with liver mitochondria suggests that the pyruvate transporter has a subunit molecular weight of 15 000 and that the 12 000-mol.wt. component may be a proteolytic breakdown product of the transporter or an additional protein that also has a thiol group protected by a-cyanocinnamate. Inclusion of 0.1 mM-phenylmethanesulphonyl fluoride, an inhibitor of some, but not all, proteinases (Sekar & Hageman, 1979) , in the preparation of Only the lower portion of the scan is shown because of the over-exposure of the film registering the higher-molecular-weight labelled proteins (see Fig. 1 ). The RF value represents the migration of the radioactive bands relative to the dye front (Bromophenol Blue). The migration of lysozyme (mol.wt. 14 500) is indicated as a reference point. using the double-incubation procedure. Densitometric scans of fluorographs from liver (a) and heart (b) mitochondrial proteins labelled by using a double-incubation procedure were prepared as described in the Experimental section. Mitochondria were incubated with N-phenylmaleimide (1 mM) in the absence (i) or in the presence (ii) of a-cyanocinnamate (0.1 mM). After being washed, the mitochondria were re-incubated with [3H]N-phenylmaleimide (1mM, 50, uCi/, umol) N-phenylmaleimide can be calculated and converted into the predicted number of carrier molecules labelled by N-phenylmaleimide in each incubation (Table 3) Measurement of the kinetics of pyruvate transport into liver and heart mitochondria by the inhibitor stop method at pH 7.2 as described previously (Halestrap, 1975) Table 4 . Estimation ofthe amount ofpyruvate transporter present in liver and heart mitochondria The data presented were calculated from the double-incubation fluorographs of liver and heart mitochondrial proteins shown in Fig. 1 (Halestrap, 1975 (Halestrap, , 1978a . A further assessment of the number of carrier molecules in heart mitochondria was made by titrating pyruvate-dependent 02 uptake in the presence of ADP with a-cyano-f,-(1-phenylindol-3-yl)acrylate at different protein concentrations. A Dixon plot (1/rate of 02 uptake against inhibitor concentration) yielded a straight line (Fig. 4a) , indicating that the pyruvate transporter was ratelimiting for respiration (see Halestrap, 1978b; Halestrap et aL, 1980) . Furthermore, the calculated K; values were linearly related to the protein concentration (Fig. 4b) , suggesting very tight binding of the inhibitor, as predicted previously (Halestrap, 1975) . The slope of this graph, 213 + 11, gives the number of pmol of inhibitor/mg of mitochondrial protein required to give 50% inhibition. If almost all the inhibitor is bound under these conditions, it would be predicted that there are 426 pmol of carrier/mg of protein, in good agreement with the labelling experiments. The predicted dissocation constant of the inhibitor-protein complex (the extrapolated K1 value at zero protein concentration) was 8.9 + 6.6 nM.
Discussion
The protection that a-cyanocinnamate affords the pyruvate transporter from inhibition by N-phenylmaleimide has allowed identification of the protein responsible for pyruvate transport. By using [3H]Nphenylmaleimide, it was shown that in liver and heart mitochondria a-cyanocinnamate specifically protected a protein of mol.wt. 15 000 from attack by this reagent. a-Cyanocinnamate also protected this protein from attack by 3H-and '4C-labelled iodoacetate, but the extent of labelling was substantially less than that seen with [3HIN-phenylmaleimide (results not shown). This is consistent with the relative effects of these two reagents on the rate of pyruvate transport (Table 1) .
The proposed molecular weight for the pyruvate carrier is considerably smaller than those of other carrier proteins characterized for mitochondria. By using similar labelling techniques the phosphate carrier has been reported to have a subunit molecular weight of about 32000 (Wohlrab, 1979; Hofmann & Kadenbach, 1979) , the ATP/ADP carrier about 30000 (see Klingenberg, 1976a,b; Klingenberg et al., 1978) and the anion channel of brown-adipose-tissue mitochondria about 32000 (Heaton et al., 1978) . It is quite possible that the functional form of the pyruvate carrier is composed of several subunits, which may or may not be identical, and therefore higher-molecular-weight components cannot be ruled out until purification and reconstitution of the carrier are attempted.
The amount of the carrier protein present in the membrane is similar to that for the components of the respiratory chain (Munn, 1974) and a little greater than the calculated amount of the phosphate carrier (30-60pmol/mg of protein in rat liver mitochondria; Coty & Pedersen, 1975; Hadvary & Kadenbach, 1976; Hofmann & Kadenbach, 1979) . The adenine nucleotide transporter is present in considerably larger quantities, as is the anion channel of brown adipose tissue (Riccio et al., 1975; Klingenberg, 1976a; Boxer et al., 1977; Heaton et al., 1978) . If it is assumed that lOOpmol of pyruvate carrier is present per mg of liver mitochondrial protein, a turnover number of the molecule can be calculated from the Vmax of transport (Halestrap, 1975 (Halestrap, , 1978a . At 0°C exchange of pyruvate for pyruvate has a Vmax of about 20nmol/min per mg of protein, giving a turnover number of 200min-1, and for net transport at pH 7.4 the value is only about 6 min-'. Even at 370 C the value for net transport rises only to about 500min-' (Halestrap, 1975 (Halestrap, , 1978b . These values are very much less than the value obtained for phosphate transport at 0°C of 3500min-1 (Coty & Pedersen, 1975) , but are nearer the value for adenine nucleotide transport at 180 C of 500 min-1 (Klingenberg, 1976a) . The relatively small turnover number of the pyruvate transporter is consistent with the suggestion that pyruvate transport may limit mitochondrial pyruvate metabolism under some conditions and so be an important site of metabolic control (see Halestrap et al., 1980) . A. P. T. holds a studentship from the Medical Research Council.
